Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease

Figure 2

Prevalence of IgA aB2GPI antibodies in age groups of transplanted patients versus blood donors.